Author

Melina Vogt

Heinrich Heine University DüsseldorfORCID 0009-0009-8608-3989Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1

Frequent Co-Authors

Sanil BhatiaiD· 3 shared Arndt BorkhardtiD· 2 shared Jia‐Wey Tu· 2 shared Niklas DienstbieriD· 2 shared Prof. Dr. Holger GohlkeiD· 2 shared Adarsh Nair· 1 shared Agata Karolina PastorczakiD· 1 shared Aleksandra A. PandyraiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

Sanil BhatiaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologyCell Death and DiseasePeer-reviewedMar 7, 2026

Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells

Julian Schliehe‐Diecks, Jia‐Wey Tu, Paweł Stachura…·Sanil Bhatia

This study shows HDAC6 inhibition enhances anti-tumoral immune responses and chemosensitivity in myeloid leukemia cells by upregulating RNase T2 and improving chromatin accessibility.

4 citationstop 2%

mouseATAC-seq

𝕏 PostBluesky

Cell BiologyCell Death and DiseasePeer-reviewedDec 23, 2025

Small-molecule inhibitor of C-terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells

Céline David, Yadong Sun, Vitalij Woloschin…·Björn Stork

This paper introduces a C-terminal HSP90 dimerization inhibitor, VWK147, which induces cell death in cisplatin-resistant cancer cells and synergizes with mTOR inhibition to enhance therapeutic efficacy.

7 citations

humanproteomics

𝕏 PostBluesky

Pharmacology & ToxicologyScientific ReportsPeer-reviewedMay 21, 2025

Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO and exhibiting an improved, selective antiproliferative effect in RUNX-ETO positive cells

Mohanraj Gopalswamy, David Bickel, Niklas Dienstbier…·Holger Gohlke

The paper identifies non-charged analogs of the inhibitor 7.44 that show improved antiproliferative effects against RUNX1-ETO positive cells.

1 citation

humanproteomics

𝕏 PostBluesky